Sanjivani Paranteral Ltd.
Snapshot View

54.85 +1.05 ▲2.0%

17 August 2022, 10:12:00 AM
Volume: 169

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sanjivani.co.in
Market Cap 53.79 Cr.
Enterprise Value(EV) 56.54 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 6.02 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 8.94 Trailing Twelve Months Ending 2022-06
Industry PE 32.22 Trailing Twelve Months Ending 2022-06
Book Value / Share -36.76 Trailing Twelve Months Ending 2022-06
Price to Book Value -1.46 Calculated using Price: 53.80
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.00 Cr. 9,998,300 Shares
FaceValue 10
Company Profile
Sanjivani Parenteral was established in 1997 by A H Khemka, Ashwin Khemka and Somesh Khemka, under the technical direction of Mahendra Kalwankar. It is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices. The core product range of the company's products includes oral solids, small volume parenterals and sterile powder formulations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.95%
1 Week
+1.57%
1 Month
+16.70%
3 Month
+15.60%
6 Month
-10.59%
1 Year
+80.13%
2 Year
+517.68%
5 Year
+591.68%
10 Year
+115.94%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 7.55 4.66 -7.19 -58.98 -596.93
Return on Capital Employed (%) 13.03 12.18 5.69 -7.28 -33.04 -227.28 -265.98 266.43
Return on Assets (%) 2.19 1.38 -2.09 -14.16 -34.18 -124.34 -9.62 -10.16 8.13

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 33 35 32 18 -9 -53 -47 -49 -45 -8
Non Curr. Liab. 9 8 7 14 9 6 10 9 7 4
Curr. Liab. 71 74 75 62 61 72 56 55 58 22
Minority Int.
Equity & Liab. 113 117 114 93 60 25 18 16 19 18
Non Curr. Assets 26 27 16 23 17 16 11 12 10 11
Curr. Assets 87 90 98 70 43 9 7 4 9 8
Misc. Exp. not W/O
Total Assets 113 117 114 93 60 25 18 16 19 18

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 152 159 133 115 33 18 25 16 25 32
Other Income 2 3 1 1 3 0 1 0 0 0
Total Income 154 161 135 116 36 18 26 17 25 33
Total Expenditure -141 -149 -128 -121 -56 -70 -27 -17 -23 -25
PBIDT 13 12 7 -5 -20 -52 -1 0 2 7
Interest -8 -8 -8 -9 -5 0 0 -1 0 0
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation -1 -1 0 0 0 0 0 0 0 0
Exceptional Items 0
PAT 2 2 -2 -15 -26 -53 -2 -2 1 6
Adjusted EPS 4 3 -4 -25 -44 -90 -4 -3 2 6

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 9 7 9 -1 0 10 3 2 0 1
Cash Fr. Inv. -8 -1 -1 9 -1 0 0 0 0 0
Cash Fr. Finan. -1 -6 -8 -7 -1 -10 -3 -2 0 0
Net Change 0 0 0 0 -1 0 0 0 0 0
Cash & Cash Eqvt 1 1 1 1 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 8.36 8.36 8.36 24.63 24.63 19.85 27.35 27.35 27.35
Public 91.64 91.64 91.64 75.37 75.37 80.15 72.65 72.65 72.65
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 09 Aug 2022
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 please find enclosed copy of newspaper publication in the following newspapers with respect to Un-Audited Financial Results for the quarter ended June 30 2022 approved at the meeting of Board of Directors held on August 08 2022: 1. Financial Express 2. Prathakal
Mon, 08 Aug 2022
Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 2022
In compliance with Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulation 2015 please find enclosed herewith the copy of Un-Audited Financial Results of the Company for the quarter ended 30th June 2022 together with a copy of the Limited Review Report as received from the Statutory Auditors of the Company.

The aforesaid Un-Audited Financial Results were approved / taken on record by the Board of Directors at their meeting held on 8th August 2022.

The Board meeting commenced at 02.45 pm and concluded at 03.15 pm .
Mon, 01 Aug 2022
Board Meeting Intimation for Quarterly Financial Results
SANJIVANI PARANTERAL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 inter alia to consider and approve 1. The Un-Audited Financial Results of the Company for the quarter ended June 30 2022. 2. Any other matter with the permission of the chair.

Technical Scans View Details >>

Tue, 16 Aug 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 1 Year High Increase 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,443.18 919.70 +0.6%
Divi's Laboratories Ltd. 99,072.87 3,767.30 +1.0%
Cipla Ltd. 83,487.41 1,031.00 -0.3%
Dr. Reddy's Laboratories Ltd. 71,536.21 4,313.05 +0.4%
Apollo Hospitals Enterprise Ltd. 62,537.70 4,325.25 -0.6%
Torrent Pharmaceuticals Ltd. 53,261.16 1,563.00 -0.7%
Piramal Enterprises Ltd. 45,983.34 1,975.20 +2.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.42 919.70 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-06 31.92 3,767.30 +1.0%
Cipla Ltd. Consolidated 2022-06 33.44 1,031.00 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.91 4,313.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.76 4,325.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.33 1,563.00 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-06 24.47 1,975.20 +2.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.38 919.70 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,767.30 +1.0%
Cipla Ltd. Consolidated 2022-06 3.87 1,031.00 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.53 4,313.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.52 4,325.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.31 1,563.00 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,975.20 +2.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 919.70 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,767.30 +1.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.00 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,313.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,325.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,563.00 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,975.20 +2.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 919.70 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,767.30 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.00 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,313.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,325.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,563.00 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,975.20 +2.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 919.70 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,767.30 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.00 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,313.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,325.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,563.00 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,975.20 +2.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 919.70 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,767.30 +1.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.00 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,313.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,325.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,563.00 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,975.20 +2.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 919.70 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,767.30 +1.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.00 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,313.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,325.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,563.00 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,975.20 +2.5%

FAQ's On Sanjivani Paranteral Ltd.

Can I Buy Sanjivani Paranteral Shares now?

What is the Share Price of Sanjivani Paranteral?

What is the Relative Strength Index (RSI) Value of Sanjivani Paranteral?

What is the Market Capital (MCAP) of Sanjivani Paranteral?

What are the key metrics to analyse Sanjivani Paranteral?

What is the Price Performance of Sanjivani Paranteral?